Are Cheaper Ozempic Knockoffs Safe? episode artwork

EPISODE · Jul 23, 2024 · 16 MIN

Are Cheaper Ozempic Knockoffs Safe?

from Big Take · host Bloomberg and iHeartPodcasts

Cheaper, knockoff versions of Ozempic, Wegovy and Zepbound are flooding the market, often promoted by telehealth companies in online ads and by influencers on TikTok and Instagram. These versions of the drugs are made by so-called compounding pharmacies, an obscure corner of America’s pharmaceutical market which makes drugs that aren’t approved by the Food and Drug Administration. On today’s Big Take podcast, Bloomberg reporters Ike Swetlitz and Madison Muller tell host Sarah Holder about their investigation into a $1 billion shadow industry that could be putting Americans’ health in danger. Read more: Unsafe Ozempic Knockoffs Are Flooding the MarketSee omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Jul 23, 2024

Embed this episode

NOW PLAYING

Are Cheaper Ozempic Knockoffs Safe?

0:00 16:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Big Take?

This episode is 16 minutes long.

When was this Big Take episode published?

This episode was published on July 23, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Big Take episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!